Literature DB >> 865938

Hypoventilation during sleep in children who have lymphoid airway obstruction treated by nasopharyngeal tube and T and A.

R E Kravath, C P Pollak, B Borowiecki.   

Abstract

Three children with sleep apnea, alveolar hypoventilation, apparent mental retardation, and poor growth associated with chronically enlarged tonsils and adenoids were treated with the use of a nasopharyngeal tube followed by tonsillectomy and adenoidectomy. The effectiveness of this therapy was documented by polygraphic recording of sleep stages and respirations, and by correlation with serial arterial blood gases and pH. The nasopharyngeal tube was well tolerated, easy to use, and effective in diagnosis and treatment. We suggest that its use be further evaluated in patients with obstructive apnea.

Entities:  

Mesh:

Year:  1977        PMID: 865938

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

Review 1.  Treatment of the obstructive sleep apnea syndrome.

Authors:  R V Wiggins; W W Schmidt-Nowara
Journal:  West J Med       Date:  1987-11

2.  Children and nocturnal snoring: evaluation of the effects of sleep related respiratory resistive load and daytime functioning.

Authors:  C Guilleminault; R Winkle; R Korobkin; B Simmons
Journal:  Eur J Pediatr       Date:  1982-11       Impact factor: 3.183

3.  Hypoxemia during oral feedings in adults with dysphagia and severe neurological disabilities.

Authors:  B Rogers; M Msall; D Shucard
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

4.  Sleep-disordered breathing and behavior in three risk groups: preliminary findings from parental reports.

Authors:  M A Carskadon; S M Pueschel; R P Millman
Journal:  Childs Nerv Syst       Date:  1993-12       Impact factor: 1.475

5.  Abnormalities of breathing control and airway maintenance in infants and children as a cause of cor pulmonale.

Authors:  C E Hunt; R T Brouillette
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.